Author

Marvin Rubenstein

Observed names: M Rubenstein, M W RUBENSTEIN, M. RUBENSTEIN, M. Rubenstein, M. W. RUBENSTEIN, M.Wm. Rubenstein, MARVIN RUBENSTEIN, Marvin Rubenstein, Ph.D, Rubenstein, M.

Observed institutions: Rush University Medical Center, University of Illinois Urbana-Champaign, Illinois Institute of Technology, John H. Stroger, Jr. Hospital of Cook County, University of Illinois Chicago, Hektoen Institute, University of Illinois Hospital & Health Sciences System, Cook County Health and Hospitals System, Rush University, Weizmann Institute of Science

OpenAlex ID: A5111553612

In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.

2009 · K M Anderson, J Jajeh, et al. · PubMed · 37

Renal cell carcinoma: Comparison of the tnm and robson stage groupings

1995 · Patrick Guinan, Robert Saffrin, et al. · Journal of Surgical Oncology · 37

Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice

1996 · Marvin Rubenstein, Yelena Mirochnik, et al. · Journal of Surgical Oncology · 36

Bone scan as a stratification variable in advanced prostate cancer

1991 · Gregory Knudson, Gedas Grinis, et al. · Cancer · 34

Correlation Between PSMA and VEGF Expression as Markers for LNCaP Tumor Angiogenesis

2005 · Paulus Tsui, Marvin Rubenstein, et al. · BioMed Research International · 30

PDF

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer

1998 · Ike Uzoaru, Marvin Rubenstein, et al. · Journal of Surgical Oncology · 28

Immunobiology of the Dunning R‐3327 Rat Prostate Adenocarcinoma Sublines: Plasma and Tumor Effusion Prostaglandins

1985 · MICHAEL W. SHAW, RICHARD J. ABLIN, et al. · American Journal of Reproductive Immunology · 28

In vivo establishment of T98G human gliobastoma

1999 · Rubenstein, M., Shaw, M., et al. · Methods and Findings in Experimental and Clinical Pharmacology · 27

Synthesis of branched antisense oligonucleotides having multiple specificities

2006 · Marvin Rubenstein, Kenning M. Anderson, et al. · Medical Hypotheses · 24

A review of antisense oligonucleotides in the treatment of human disease

2004 · Rubenstein, M., Tsui, P., et al. · Drugs of the Future · 23

A qualitative analysis of acidic proteins associated with regressing, growing, or dividing rat ventral prostate cells

1983 · K. M. Anderson, J. Baranowski, et al. · The Prostate · 22

Isolation of Viable Rat Ventral Prostate Epithelial and Nonepithelial Cells*

1980 · M. RUBENSTEIN, K. M. ANDERSON · Endocrinology · 22

Bispecific antisense oligonucleotides with multiple binding sites for the treatment of prostate tumors and their applicability to combination therapy

2006 · Rubenstein, M., Tsui, P., et al. · Methods and Findings in Experimental and Clinical Pharmacology · 19

Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides

1998 · Rubenstein, M., Mirochnik, Y., et al. · Methods and Findings in Experimental and Clinical Pharmacology · 19

Report of 337 patients with renal cell carcinoma emphasizing 110 with Stage IV disease and review of the literature

1997 · Patrick Guinan, David Stuhldreher, et al. · Journal of Surgical Oncology · 19

Staging and survival of patients with renal cell carcinoma

1994 · Patrick Guinan, Walter Frank, et al. · Seminars in Surgical Oncology · 19

Relationship of Arachidonic Acid Metabolism to Indomethacin-Sensitive Immunoregujatory Function and Lymphocyte PGE Sensitivity in Peripheral Blood Mononuclear Cells of Disseminated Solid Tumor Cancer Patients

1984 · D. P. Braun, J. E. Harris, et al. · Journal of Immunopharmacology · 19

Bispecific antisense oligonucleotides have activity comparable to monospecifics in inhibiting expression of BCL-2 in LNCaP cells.

2010 · Marvin Rubenstein, Patrick Guinan · PubMed · 18

Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors

2008 · Marvin Rubenstein, Paulus Tsui, et al. · Medical Oncology · 17

Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

2007 · Marvin Rubenstein, Paulus Tsui, et al. · Medical Oncology · 17

Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2

2009 · Marvin Rubenstein, Paulus Tsui, et al. · Medical Oncology · 15

Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors

2005 · Marvin Rubenstein, Paulus Tsui, et al. · Medical Hypotheses · 15

Treatment of the T98G Glioblastoma Cell Line with Antisense Oligonucleotides Directed Toward mRNA Encoding Transforming Growth Factor-α and the Epidermal Growth Factor Receptor

2001 · Marvin Rubenstein, Roberta Glick, et al. · Medical Oncology · 15

The effect of androgen deprivation on malignant and benign prostate tissue

1997 · Patrick Guinan, David Didomenico, et al. · Medical Oncology · 15

Lymphocyte subsets in urologic cancer patients

1987 · M. Shaw, P. Ray, et al. · Urological Research · 15

Works count: 159

Citation count: 1,068

H-index: 18

I10-index: 40